
Platform Biotech Models Draw Investor Eyes as Drug-Delivery Markets Head Toward $410 Billion
Biotech companies are shifting focus to scalable nanotechnology-driven drug delivery platforms to enhance existing cancer therapies, with the market projected to reach $410 billion, highlighting a strategic move from drug discovery to delivery innovation.
Read full story























